|Articles|August 18, 2014

Special Reports

  • Immunotherapy (Issue 3)
  • Volume 3
  • Issue 1

Future Immune Checkpoint Strategies

James P. Allison, PhD, director, immunotherapy platform, The University of Texas MD Anderson Cancer Center, discusses the future of immune checkpoint strategies.

James P. Allison, PhD, director, immunotherapy platform, The University of Texas MD Anderson Cancer Center, discusses the future of immune checkpoint strategies.

Learn about the history of immunotherapy > >


Latest CME